
Pfizer Investment Enterprises Pte. Ltd, founded in Singapore, operates as a wholly-owned subsidiary of Pfizer Inc., focusing on strategic investments to support the global pharmaceutical development and commercialization efforts of its parent company. The firm specializes in offering financing solutions and managing treasury functions in line with Pfizer's corporate objectives, thereby enhancing liquidity and capital structure efficiency.
Bond Name | Country | Maturity | Coupon(%) | |
---|---|---|---|---|
PFE 4.45% 2026-05-19 USDPfizer Investment Enterprises Pte. Ltd | Singapore | 2026-05-19 | 4.450 | 4.20 |
PFE 4.45% 2028-05-19 USDPfizer Investment Enterprises Pte. Ltd | Singapore | 2028-05-19 | 4.450 | 3.87 |
PFE 4.65% 2025-05-19 USDPfizer Investment Enterprises Pte. Ltd | United States | 2025-05-19 | 4.650 | 0.00 |
PFE 4.65% 2030-05-19 USDPfizer Investment Enterprises Pte. Ltd | Singapore | 2030-05-19 | 4.650 | 4.04 |
PFE 4.75% 2033-05-19 USDPfizer Investment Enterprises Pte. Ltd | Singapore | 2033-05-19 | 4.750 | 4.51 |
PFE 5.11% 2043-05-19 USDPfizer Investment Enterprises Pte. Ltd | Singapore | 2043-05-19 | 5.110 | 5.37 |
PFE 5.30% 2053-05-19 USDPfizer Investment Enterprises Pte. Ltd | Singapore | 2053-05-19 | 5.300 | 5.58 |
PFE 5.34% 2063-05-19 USDPfizer Investment Enterprises Pte. Ltd | Singapore | 2063-05-19 | 5.340 | 5.69 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
The company has actively participated in the bond market since its inception, with notable bond issuances starting in 2015, aimed at funding research and development projects. One of its significant issuances occurred in 2020, when it raised $2 billion in a green bond offering, targeting environmental sustainability initiatives. Current yields on its bonds are competitive at approximately 2.5%, aligning well with industry benchmarks. Pfizer Investment Enterprises also offers bonds with innovative features, such as callable options, which provide flexibility for refinancing in favorable market conditions.